| 1. |
Roberts, A. B. (1998) Molecular and cell biology of TGF-beta. Miner. Electrolyte Metab.
24(2–3), 111–119.
|
| |
| 2. |
de Caestecker, M. P., Piek, E., and Roberts, A. B. (2000) Role of transforming growth factor-beta signaling in cancer. J. Natl. Cancer Inst.
92(17), 1388–1402.
|
| |
| 3. |
Chen, W. and Wahl, S. M. (2002) TGF-beta: receptors, signaling pathways and autoimmunity. Curr. Dir. Autoimmun.
5, 62–91.
|
| |
| 4. |
Varga, J. (2002) Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis. Arthritis Rheum.
46(7), 1703–1713.
|
| |
| 5. |
Barcellos-Hoff, M. H. (1996) Latency and activation in the control of TGF-beta. J. Mammary Gland Biol. Neoplasia.
1(4), 353–363.
|
| |
| 6. |
Attisano, L. and Wrana, J. L. (2002) Signal transduction by the TGF-beta superfamily. Science
296(5573), 1646–1647.
|
| |
| 7. |
Shi, Y. and Massague, J. (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell
113(6), 685–700.
<Occurrence Type="DOI"><Handle>10.1016/S0092-8674(03)00432-X</Handle></Occurrence>
|
| |
| 8. |
Huse, M., Muir, T. W., Xu, L., Chen, Y. G., Kuriyan, J., and Massague, J. (2001) The TGF beta receptor activation process:
an inhibitor-to substrate-binding switch. Mol. Cell.
8(3), 671–682.
<Occurrence Type="DOI"><Handle>10.1016/S1097-2765(01)00332-X</Handle></Occurrence>
|
| |
| 9. |
Di Guglielmo, G. M., LeRoy, C., Goodfellow, A. E., and Wrana, J. L. (2003) Distinct endocytic pathways regulate TGF-beta receptor
signalling and turnover. Nat. Cell Biol.
5(5), 410–421.
|
| |
| 10. |
Lopez-Casillas, F., Wrana, J. L., and Massagué, J. (1993) Betaglycan presents ligand to the TGF beta signaling receptor. Cell
73(7), 1435–1444.
<Occurrence Type="DOI"><Handle>10.1016/0092-8674(93)90368-Z</Handle></Occurrence>
|
| |
| 11. |
Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L., and Wrana, J. L. (1998) SARA, a FYVE domain protein that recruits
Smad2 to the TGFbeta receptor. Cell
95(6), 779–791.
<Occurrence Type="DOI"><Handle>10.1016/S0092-8674(00)81701-8</Handle></Occurrence>
|
| |
| 12. |
Reguly, T. and Wrana, J. L. (2003) In or out? The dynamics of Smad nucleocytoplasmic shuttling. Trends Cell Biol.
13(5), 216–220.
<Occurrence Type="DOI"><Handle>10.1016/S0962-8924(03)00075-8</Handle></Occurrence>
|
| |
| 13. |
Fink, S. P., Mikkola, D., Wilson, J. K., and Markowitz, S. (2003) TGF-betainduced nuclear localization of Smad2 and Smad3
in Smad4 null cancer cell lines. Oncogene
22(9), 1317–1323.
|
| |
| 14. |
Zawel, L., Dai, J. L., Buckhaults, P., et al. (1998) Human Smad3 and Smad4 are sequence-specific transcription activators.
Mol. Cell.
1(4), 611–617.
<Occurrence Type="DOI"><Handle>10.1016/S1097-2765(00)80061-1</Handle></Occurrence>
|
| |
| 15. |
Dennler, S., Huet, S., and Gauthier, J. M. (1999) A short amino-acid sequence in MH1 domain is responsible for functional
differences between Smad2 and Smad3. Oncogene
18(8), 1643–1648.
|
| |
| 16. |
Attisano, L., Silvestri, C., Izzi, L., and Labbe, E. (2001) The transcriptional role of Smads and FAST (FoxH1) in TGFbeta
and activin signalling. Mol. Cell Endocrinol.
180(1–2), 3–11.
<Occurrence Type="DOI"><Handle>10.1016/S0303-7207(01)00524-X</Handle></Occurrence>
|
| |
| 17. |
Miyazono, K. (2000) TGF-beta signaling by Smad proteins. Cytokine Growth Factor Rev.
11(1–2), 15–22.
<Occurrence Type="DOI"><Handle>10.1016/S1359-6101(99)00025-8</Handle></Occurrence>
|
| |
| 18. |
Datta, P. K., Chytil, A., Gorska, A. E., and Moses, H. L. (1998) Identification of STRAP, a novel WD domain protein in transforming
growth factor-beta signaling. J. Biol. Chem.
273(52), 34,671–34,674.
|
| |
| 19. |
Ferrigno, O., Lallemand, F., Verrecchia, F., et al. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its
inhibitory activity against TGF-beta/Smad signaling. Oncogene
21(32), 4879–4884.
|
| |
| 20. |
Janknecht, R., Wells, N. J., and Hunter, T. (1998) TGF-beta-stimulated cooperation of smad proteins with the coactivators
CBP/p300. Genes Dev.
12(14), 2114–2119.
|
| |
| 21. |
Feng, X. H., Zhang, Y., Wu, R. Y., and Derynck, R. (1999) The tumor suppressor Smad4/DPC4 and transcriptional adaptor CBP/p300
are coactivators for smad3 in TGF-beta-induced transcriptional activation. Genes Dev.
12(14), 2153–2163.
|
| |
| 22. |
Pouponnot, C., Jayaraman, L., and Massagué, J. (1998) Physical and functional interaction of SMADs and p300/CBP. J. Biol. Chem.
273(36), 22,865–22,968.
|
| |
| 23. |
Shen, X., Hu, P. P., Liberati, N. T., Datto, M. B., Frederick, J. P., and Wang, X. F. (1998) TGF-beta-induced phosphorylation
of Smad3 regulates its interaction with coactivator p300/CREB-binding protein. Mol. Biol. Cell.
9(12), 3309–3319.
|
| |
| 24. |
Topper, J. N., Dichiara, M. R., Brown, J. D., et al. (1998) CREB binding protein is a required coactivator for Smad-dependent,
transforming growth factor beta transcriptional responses in endothelial cells. Proc. Natl. Acad. Sci. USA
95(16), 9506–9511.
|
| |
| 25. |
Verrecchia, F., Pessah, M., Afti, A., and Mauviel, A. (2000) Tumor necrosis factor-alpha inhibits transforming growth factor-beta
/Smad signaling in human dermal fibroblasts via AP-1 activation. J. Biol. Chem.
275(39), 30,226–30,231.
|
| |
| 26. |
Ghosh, A. K., Yuan, W., Mori, Y., Chen, S. J., and Varga, J. (2001) Antagonistic regulation of type I collagen gene expression
by interferon-gamma and transforming growth factor-beta. Integration at the level of p300/CBP transcriptional coactivators.
J. Biol. Chem.
276(14), 11,041–11,048.
|
| |
| 27. |
Schiller, M., Verrecchia, F., and Mauviel, A. (2003) Cyclic adenosine 3′,5′-monophosphate-elevating agents inhibit transforming
growth factor-beta-induced SMAD3/4-dependent transcription via a protein kinase A-dependent mechanism. Oncogene
22(55), 8881–8890.
|
| |
| 28. |
Wotton, D., Lo, R. A., Lee, S., and Massague, J. (1999) A Smad transcriptional corepressor. Cell
97(1), 29–39.
<Occurrence Type="DOI"><Handle>10.1016/S0092-8674(00)80712-6</Handle></Occurrence>
|
| |
| 29. |
Luo, K., Stroschein, S. L., Wang, W., et al. (1999) The Ski oncoprotein interacts with the Smad proteins to repress TGFbeta
signaling. Genes Dev.
13(17), 2196–2206.
|
| |
| 30. |
Sun, Y., Liu, X., Ng-Eaton, E., Lodish, H. F., and Weinberg, R. A. (1999) SnoN and Ski protooncoproteins are rapidly degraded
in response to transforming growth factor beta signaling. Proc. Natl. Acad. Sci. USA
96(22), 12,442–12,447.
|
| |
| 31. |
Kim, R. H., Wang, D., Tsang, M., et al. (2000) A novel smad nuclear interacting protein, SNIP1, suppresses p300-dependent
TGF-beta signal transduction. Genes Dev.
14(13), 1605–1616.
|
| |
| 32. |
Verrecchia, F. and Mauviel, A. (2002) Control of connective tissue gene expression by TGF beta: role of Smad proteins in fibrosis.
Curr. Rheumatol. Rep.
4(2), 143–149.
|
| |
| 33. |
O’Kane, S. and Ferguson, M. W. (1997) Transforming growth factor beta s and wound healing. Int. J. Biochem. Cell Biol.
29(1), 63–78.
<Occurrence Type="DOI"><Handle>10.1016/S1357-2725(96)00120-3</Handle></Occurrence>
|
| |
| 34. |
Bitzer, M., von Gersdorff, G., Liang, D., et al. (2000) A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa
B/RelA. Genes Dev.
14(2), 187–197.
|
| |
| 35. |
Verrecchia, F., Tacheau, C., Wagner, E. G., and Mauviel, A. (2003) A central role for the JNK pathway in mediating the antagonistic
activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression. J. Biol. Chem.
278(3), 1585–1593.
|
| |
| 36. |
Verrecchia, F., Wagner, E. F., and Mauviel, A. (2002) Distinct involvement of the Jun-N-terminal kinase and NF-κB pathways
in the repression of the human COL1A2 gene by TNF-α. EMBO Rep.
3(11), 1069–1074.
|
| |
| 37. |
Han, Z., Boyle, D. L., Chang, L., et al. (2001) c-Jun N-terminal kinase is required for metalloproteinase expression and joint
destruction in inflammatory arthritis. J. Clin. Invest.
108(1), 73–81.
|
| |
| 38. |
Ulloa, L., Doody, J., and Massagué, J. (1999) Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT
pathway. Nature
397(6721), 710–713.
|
| |
| 39. |
Higashi, K., Kouba, D. J., Song, Y. J., Uitto, J., and Mauviel, A. (1998) A proximal element within the human alpha 2(I) collagen
(COL1A2) promoter, distinct from the tumor necrosis factor-alpha response element, mediates transcriptional repression by
interferon-gamma. Matrix Biol.
16(8), 447–456.
<Occurrence Type="DOI"><Handle>10.1016/S0945-053X(98)90016-6</Handle></Occurrence>
|
| |
| 40. |
Higashi, K., Inagaki, Y., Fujimori, K., Nakao, A., Kaneko, H., and Nakatsuka, I. (2003) Interferon-gamma interferes with transforming
growth factor-beta signaling through direct interaction of YB-1 with Smad3. J. Biol. Chem.
278(44), 43,470–43,479.
|
| |
| 41. |
Ashcroft, G. S., Yang, X., Glick, A. B., et al. (1999) Mice lacking Smad3 show accelerated wound healing and an impaired local
inflammatory response. Nat. Cell Biol.
1(5), 260–266.
|
| |
| 42. |
Flanders, K. C., Sullivan, C. D., Fujii, M., et al. (2002) Mice lacking Smad3 are protected against cutaneous injury induced
by ionizing radiation. Am. J. Pathol.
160(3), 1057–1068.
|
| |
| 43. |
Sato, M., Muragaki, Y., Saika, S., Roberts, A. B., and Ooshmia, A. (2003) Targeted disruption of TGF-β1/Smad3 signaling protects
against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J. Clin. Invest.
112(10), 1486–1494.
|
| |
| 44. |
Wang, B., Hao, J., Jones, S. C., Yee, M. S., Roth, J. C., and Dixon, I. M. (2002) Decreased Smad 7 expression contributes
to cardiac fibrosis in the infarcted rat heart. Am. J. Physiol. Heart Circ. Physiol.
282(5), H1685–1696.
|
| |
| 45. |
Wang, H., Yang, G. H., Bu, H., Zhou, Q., Gui, L. X., Wang, S. L., and Ye, L. (2003) Systematic analysis of the TGF-beta/Smad
signalling pathway in the Rhabdomyosarcoma cell line RD. Int. J. Exp. Pathol.
84(3), 153–163.
|
| |
| 46. |
Mori, Y., Chen, S. J., and Varga, J. (2003) Expression and regulation of intracellular SMAD signaling in scleroderma skin
fibroblasts. Arthritis Rheum.
48(7), 1964–1978.
|
| |
| 47. |
Nakao, A., Fujii, M., Matsumura, R., et al. (1999) Transient gene transfer and expression of Smad7 prevents bleomycin-induced
lung fibrosis in mice. J. Clin. Invest.
104(1), 5–11.
|
| |
| 48. |
Lan, H. Y., Mu, W., Tomita, N., et al. (2003) Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble
system in rat UUO model. J. Am. Soc. Nephrol.
14(6), 1535–1548.
|
| |
| 49. |
Dooley, S., Hamzavi, J., Breitkopf, K., et al. (2003) Smad7 prevents activation of hepatic stellate cells and liver fibrosis
in rats. Gastroenterology
125(1), 178–191.
<Occurrence Type="DOI"><Handle>10.1016/S0016-5085(03)00666-8</Handle></Occurrence>
|
| |
| 50. |
Laping, N. J., Grygielko, E., Mathur, A., et al. (2002) Inhibition of transforming growth factor (TGF)-beta1-induced extracellular
matrix with a novel inhibitor of the TGF-beta type I receptor kinase activity: SB-431542. Mol. Pharmacol. 62(10), 58–64.
|
| |
| 51. |
Grygeiklo, E. T., Martin, W. M., Tweed, C. W., et al. (2005) Inhibition of gene markers of fibrosis with a novel inhibitor
of TGFta-type I receptor kinase in puromycin-induced nephritis. J. Pharmacol. Exp. Ther. [Epub ahead of print].
|
| |
| 52. |
Bonniaud, P., Margetts, P. J., Kolb, M., et al. (2005) Progressive transforming growth factor {beta}1-induced lung fibrosis
is blocked by an orally active ALK5 kinase inhibitor. Am. J. Resp. Crit. Care Med. 171(8), 889–898.
|
| |
| 53. |
de Gouville, A. C., Boullay, V., Krysa, G., et al. (2005) Inhibition of TGF-beta signaling by an ALK5 inhibitor protects rats
from dimethylnitrosamine-induced liver fibrosis. Br. J. Pharmacol. [Epub ahead of print].
|
| |
| 54. |
Yang, Y. A., Dukhanina, O., Tang, B., et al. (2002) Lifetime exposure to a soluble TGF-beta antagonist protects mice against
metastasis without adverse side effects. J. Clin. Invest.
109(12), 1607–1615.
|
| |
| 55. |
He, W., Li, A. G., Wang, D., et al. (2002) Overexpression of Smad7 results in severe pathological alterations in multiple
epithelial tissues. EMBO J.
21(11), 2580–2590.
|
| |
| 56. |
Denton, C. P., Zheng, B., Evans, L. A., et al. (2003) Fibroblast-specific expression of a kinase-deficient type II transforming
growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic
mice. J. Biol. Chem.
278(27), 25,109–25,119.
|
| |
| 57. |
Javelaud, D. and Mauviel, A. (2004) Mammalian transforming growth factorbetas: Smad signaling and physio-pathological roles.
Int. J. Biochem. Cell Biol.
36, 1161–1165.
<Occurrence Type="DOI"><Handle>10.1016/S1357-2725(03)00255-3</Handle></Occurrence>
|
| |